Trial Profile
Part A: a Prospective, Randomized, Double-masked, Vehicle Controlled, Paired-eye Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability and Efficacy of Elamipretide Topical Ophthalmic Solution in Subjects With Fuchs' Corneal Endothelial Dystrophy (FCED) Presenting With Mild to Moderate Corneal Edema Part B: a Prospective, Randomized, Double-masked, Vehicle Controlled, Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution in Subjects With FCED Presenting With Mild to Moderate Corneal Edema
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Sep 2021
Price :
$35
*
At a glance
- Drugs Elamipretide (Primary)
- Indications Corneal disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Stealth BioTherapeutics
- 17 Jul 2019 Status changed from active, no longer recruiting to completed.
- 24 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2017 Status changed from active, no longer recruiting to recruiting.